6 children with refractory aml , 9 children with bone-marrow relapse during or after maintenance therapy and 4 children with residual blasts ( 5-25 % ) after remission induction and consolidation therapy aml-bfm 83 were treated with the relapse protocol .
C0005953
bone-marrow
C0023467
aml